Global Health: Gilead Will Donate Truvada to U.S. for H.I.V. Prevention

The manufacturer will provide enough of the drug to supply 200,000 patients annually for more than a decade. Critics said it would not be enough to end the AIDS epidemic and questioned the company ’ s motives.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Acquired Immune Deficiency Syndrome Truvada (Drug) Generic Brands and Products State of the Union Message (US) Gilead Sciences Inc United States Drugs (Pharmaceuticals) Source Type: news